Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits
Autism Spectrum Disorders (ASD) may significantly impact the well-being of patients and their families. The therapeutic use of cannabis for ASD has gained interest due to its promising results and low side effects, but a consensus on treatment guidelines is lacking. In this study, we conducted a ret...
Main Authors: | Patrícia Soares Silva Montagner, Wesley Medeiros, Leandro Cruz Ramires da Silva, Clarissa Nogueira Borges, Joaquim Brasil-Neto, Vinícius de Deus Silva Barbosa, Fabio V. Caixeta, Renato Malcher-Lopes |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1210155/full |
Similar Items
-
Oral Cannabis consumption and intraperitoneal THC:CBD dosing results in changes in brain and plasma neurochemicals and endocannabinoids in mice
by: Nichole Reisdorph, et al.
Published: (2024-03-01) -
The Effect of Orally Administered Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on Obesity Parameters in Mice
by: Adi Eitan, et al.
Published: (2023-09-01) -
THC-Reduced <i>Cannabis sativa</i> L.—How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?
by: Joanna Bartkowiak-Wieczorek, et al.
Published: (2023-06-01) -
<i>Cannabis Sativa</i> Revisited—Crosstalk between microRNA Expression, Inflammation, Oxidative Stress, and Endocannabinoid Response System in Critically Ill Patients with Sepsis
by: Anca Raluca Dinu, et al.
Published: (2020-01-01) -
Cannabis and cannabinoid medications for the treatment of chronic orofacial pain: A scoping review
by: Jory Longworth, et al.
Published: (2023-03-01)